Milnacipran plasma levels and antidepressant response in Japanese major depressive patients-Reference-Cited by-同舟云学术

Milnacipran plasma levels and antidepressant response in Japanese major depressive patients

Published:2003 Issue:4 Volume:18 Page:255-259
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Higuchi Hisashi,Yoshida Keizo,Takahashi Hitoshi,Naito Shingo,Kamata Mitsuhiro,Ito Kenichi,Sato Kazuhiro,Tsukamoto Kei,Shimizu Tetsuo,Nakanishi Mamoru,Hishikawa Yasuo

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference14 articles.

1. Relationship between Plasma Level and Therapeutic Effect of Nortriptyline

2. AMITRIPTYLINE PLASMA-CONCENTRATION AND CLINICAL EFFECT

3. Clinical Implications of Imipramine Plasma Levels for Depressive Illness

4. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry

5. Remarkable effect of milnacipran in the treatment of Japanese major depressive patients

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update Lessons from PET Imaging Part II: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antidepressants;Therapeutic Drug Monitoring;2024-01-24

2. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12

3. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017;Pharmacopsychiatry;2017-09-14

4. Duloxetine Plasma Concentrations and Its Effectiveness in the Treatment of Nonorganic Chronic Pain in the Orofacial Region;Clinical Neuropharmacology;2017-07

5. Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression;Neuropsychiatric Disease and Treatment;2017-06